首页 > 最新文献

Pharmaceutica Analytica Acta最新文献

英文 中文
Innovative and Useful Approaches on Trace Determinations of Organic and Inorganic Analytes 有机和无机分析物痕量测定的创新和有用方法
Pub Date : 2019-01-01 DOI: 10.35248/2153-2435.19.10.606
Ulusoy Hi
Sample pretreatment procedures is one of the most important steps in analysis of complex samples. Even a research laboratory has complicated or sensitive instruments, it is not easy to obtain reliable results if all variables can be considered carefully in your samples. All over the world, most of analytical chemists try to find new methods and develop new materials for sensitive and correct analysis of target species. Prior to analysis in instrumental tools, sample preparation is a critical step affecting all results. Accuracy and reliability of results are directly affected by these steps. An ideal pretreatment procedure should be simple, cost effective, environmental friendly and compatible detection method. There are two fundamental goal of pre-treatment procedures; separation of matrix components and pre-concentration of trace analyte species. If a method can accomplish one of these goals, a conventional analysis approaches will be more sensitive or selective for trace analyte species. This paper includes a few useful approaches of our research group for trace determination of organic and inorganic species. Each of method focus on a target ion or molecule by using a pre-concentration method such as cloud point extraction (CPE), solid phase extraction (SPE), and magnetic solid phase extraction (MSPE), fabric phase sorptive extraction (FPSE). Application of developed method was carried out in various complex samples including food, cosmetic, water and other environmental samples.
样品前处理是复杂样品分析的重要步骤之一。即使一个研究实验室有复杂或敏感的仪器,如果在你的样品中所有的变量都可以仔细考虑,那么获得可靠的结果是不容易的。在世界范围内,大多数分析化学家都在努力寻找新的方法和开发新的材料,以便对目标物种进行灵敏和正确的分析。在仪器分析之前,样品制备是影响所有结果的关键步骤。这些步骤直接影响结果的准确性和可靠性。理想的预处理程序应该是简单、经济、环保和兼容的检测方法。预处理程序有两个基本目标;基质组分的分离和痕量分析物的预富集。如果一种方法可以实现这些目标之一,传统的分析方法将对痕量分析物更敏感或有选择性。本文介绍了本课题组在有机和无机物质痕量测定中的几种有用方法。每一种方法都是通过使用预先富集的方法,如云点萃取(CPE)、固相萃取(SPE)和磁固相萃取(MSPE)、织物相吸附萃取(FPSE)来聚焦于目标离子或分子。将该方法应用于食品、化妆品、水和其他环境样品等复杂样品中。
{"title":"Innovative and Useful Approaches on Trace Determinations of Organic and Inorganic Analytes","authors":"Ulusoy Hi","doi":"10.35248/2153-2435.19.10.606","DOIUrl":"https://doi.org/10.35248/2153-2435.19.10.606","url":null,"abstract":"Sample pretreatment procedures is one of the most important steps in analysis of complex samples. Even a research laboratory has complicated or sensitive instruments, it is not easy to obtain reliable results if all variables can be considered carefully in your samples. All over the world, most of analytical chemists try to find new methods and develop new materials for sensitive and correct analysis of target species. Prior to analysis in instrumental tools, sample preparation is a critical step affecting all results. Accuracy and reliability of results are directly affected by these steps. An ideal pretreatment procedure should be simple, cost effective, environmental friendly and compatible detection method. There are two fundamental goal of pre-treatment procedures; separation of matrix components and pre-concentration of trace analyte species. If a method can accomplish one of these goals, a conventional analysis approaches will be more sensitive or selective for trace analyte species. This paper includes a few useful approaches of our research group for trace determination of organic and inorganic species. Each of method focus on a target ion or molecule by using a pre-concentration method such as cloud point extraction (CPE), solid phase extraction (SPE), and magnetic solid phase extraction (MSPE), fabric phase sorptive extraction (FPSE). Application of developed method was carried out in various complex samples including food, cosmetic, water and other environmental samples.","PeriodicalId":19833,"journal":{"name":"Pharmaceutica Analytica Acta","volume":"59 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80543962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Silico Design, Synthesis and Characterization of New Spebrutinib Analogues 新型Spebrutinib类似物的硅设计、合成和表征
Pub Date : 2019-01-01 DOI: 10.35248/2153-2435.19.10.612
Z. Al-Obaidi, Omar F. Abdul-Rasheed, M. F. Mahdi, Ayad M. R. Raauf
Background: Recently, in silico or computer-aided drug design has emerged as a cornerstone on the harbor of modern drug discovery. One of the approaches to treat cancer is the inhibition of tyrosine kinase, which is considered as a key enzyme in the survival of the cancerous cells. Spebrutinib, as a member of the tyrosine kinase inhibitors, has few unwanted side effects due to its off-target bindings. In this work, the GOLD program was employed to predict the bindings and thus the inhibitory activity toward the tyrosine kinase. Methodology: After the design and docking processes, the chemical synthesis of three spebrutinib analogues was achieved. Results: The percent yields of the chemical syntheses were ranged from 81% to 89%. These analogues were characterized utilizing; FT-IR, DSC, CHN, and 1H NMR. In conclusion, these new spebrutinib analogues were successfully designed, synthesized, and characterized. However, these analogues are potential anticancer agents and biological activity against cancerous and toxicity pattern against normal cells are crucial to affirm the present findings.
背景:近年来,计算机或计算机辅助药物设计已成为现代药物发现的基石。治疗癌症的方法之一是抑制酪氨酸激酶,酪氨酸激酶被认为是癌细胞存活的关键酶。Spebrutinib作为酪氨酸激酶抑制剂的一员,由于其脱靶结合,几乎没有不良副作用。在这项工作中,黄金程序被用来预测结合,从而对酪氨酸激酶的抑制活性。方法:经过设计和对接过程,实现了三种spebrutinib类似物的化学合成。结果:化学合成收率为81% ~ 89%。这些类似物是利用;FT-IR, DSC, CHN,和1H NMR。总之,这些新的斯佩鲁替尼类似物被成功地设计、合成和表征。然而,这些类似物是潜在的抗癌药物,对癌细胞的生物活性和对正常细胞的毒性模式是确认本研究结果的关键。
{"title":"In Silico Design, Synthesis and Characterization of New Spebrutinib Analogues","authors":"Z. Al-Obaidi, Omar F. Abdul-Rasheed, M. F. Mahdi, Ayad M. R. Raauf","doi":"10.35248/2153-2435.19.10.612","DOIUrl":"https://doi.org/10.35248/2153-2435.19.10.612","url":null,"abstract":"Background: Recently, in silico or computer-aided drug design has emerged as a cornerstone on the harbor of modern drug discovery. One of the approaches to treat cancer is the inhibition of tyrosine kinase, which is considered as a key enzyme in the survival of the cancerous cells. Spebrutinib, as a member of the tyrosine kinase inhibitors, has few unwanted side effects due to its off-target bindings. In this work, the GOLD program was employed to predict the bindings and thus the inhibitory activity toward the tyrosine kinase. Methodology: After the design and docking processes, the chemical synthesis of three spebrutinib analogues was achieved. Results: The percent yields of the chemical syntheses were ranged from 81% to 89%. These analogues were characterized utilizing; FT-IR, DSC, CHN, and 1H NMR. In conclusion, these new spebrutinib analogues were successfully designed, synthesized, and characterized. However, these analogues are potential anticancer agents and biological activity against cancerous and toxicity pattern against normal cells are crucial to affirm the present findings.","PeriodicalId":19833,"journal":{"name":"Pharmaceutica Analytica Acta","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88676496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Quantitative Determination of Brexpiprazole by RP-HPLC Method 反相高效液相色谱法测定布雷哌唑的含量
Pub Date : 2019-01-01 DOI: 10.35248/2153-2435.19.10.610
Veera S. Pulusu, Krishna C. Routhu, Soma SB. Chikkaswamy
{"title":"Quantitative Determination of Brexpiprazole by RP-HPLC Method","authors":"Veera S. Pulusu, Krishna C. Routhu, Soma SB. Chikkaswamy","doi":"10.35248/2153-2435.19.10.610","DOIUrl":"https://doi.org/10.35248/2153-2435.19.10.610","url":null,"abstract":"","PeriodicalId":19833,"journal":{"name":"Pharmaceutica Analytica Acta","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73743348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Molecular Docking Studies for Design, Synthesis and Characterization of New Imatinib Analogues 新型伊马替尼类似物设计、合成与表征的分子对接研究
Pub Date : 2019-01-01 DOI: 10.35248/2153-2435.19.10.616
A. Hussein, O. Rasheed, M. F. Mahdi, Ayad M. R. Raauf
Background: In silico drug design conducts a process for making conformations and directions of multiple ligands and chooses the best ones, then being selected. In silico studies are used to examine and model molecular interactions between target macromolecules and ligand. Tyrosine kinase is considered a potential target to design inhibitors. Tyrosine kinase inhibitor like imatinib this drug has succeeded to pass through clinical studies in an attempt to cure the cancer, which is considered as the second leading cause of deaths in the world. In this work, the GOLD program was employed to predict the bindings and thus the inhibitory activity toward the tyrosine kinase. Methodology: After the design and docking processes, the chemical synthesis of three imatinib analogues was achieved. Results: the percent of yield of the chemical synthesis was (81-85%). The synthesized compounds were well characterized using FTIR, NMR, DSC, and CHN elemental analyser. The present purity was within the globally accepted value of less than 0.4% with the employment of CHN combustion.
背景:硅药物设计是对多个配体的构象和方向进行确定,并从中选择最佳配体,然后进行筛选的过程。在硅研究被用来检查和模拟分子之间的相互作用目标大分子和配体。酪氨酸激酶被认为是设计抑制剂的潜在靶点。像伊马替尼这样的酪氨酸激酶抑制剂已经成功地通过了临床研究,试图治愈被认为是世界上第二大死亡原因的癌症。在这项工作中,黄金程序被用来预测结合,从而对酪氨酸激酶的抑制活性。方法:经过设计和对接过程,实现了三种伊马替尼类似物的化学合成。结果:化学合成收率为(81 ~ 85%)。用FTIR、NMR、DSC和CHN元素分析仪对合成的化合物进行了表征。采用CHN燃烧,目前的纯度在全球公认的0.4%以内。
{"title":"Molecular Docking Studies for Design, Synthesis and Characterization of New Imatinib Analogues","authors":"A. Hussein, O. Rasheed, M. F. Mahdi, Ayad M. R. Raauf","doi":"10.35248/2153-2435.19.10.616","DOIUrl":"https://doi.org/10.35248/2153-2435.19.10.616","url":null,"abstract":"Background: In silico drug design conducts a process for making conformations and directions of multiple ligands and chooses the best ones, then being selected. In silico studies are used to examine and model molecular interactions between target macromolecules and ligand. Tyrosine kinase is considered a potential target to design inhibitors. Tyrosine kinase inhibitor like imatinib this drug has succeeded to pass through clinical studies in an attempt to cure the cancer, which is considered as the second leading cause of deaths in the world. In this work, the GOLD program was employed to predict the bindings and thus the inhibitory activity toward the tyrosine kinase. Methodology: After the design and docking processes, the chemical synthesis of three imatinib analogues was achieved. Results: the percent of yield of the chemical synthesis was (81-85%). The synthesized compounds were well characterized using FTIR, NMR, DSC, and CHN elemental analyser. The present purity was within the globally accepted value of less than 0.4% with the employment of CHN combustion.","PeriodicalId":19833,"journal":{"name":"Pharmaceutica Analytica Acta","volume":"146 1","pages":"1-9"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77738515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Quantitative Estimation of Dapagliflozin in Blood Plasma by Using UV Spectroscopy 紫外光谱法定量测定血浆中达格列净的含量
Pub Date : 2019-01-01 DOI: 10.35248/2153-2435.19.10.608
Bhagwat J Bodade, Dhiraj A Kanade, Sandip S Chaudhari
{"title":"Quantitative Estimation of Dapagliflozin in Blood Plasma by Using UV Spectroscopy","authors":"Bhagwat J Bodade, Dhiraj A Kanade, Sandip S Chaudhari","doi":"10.35248/2153-2435.19.10.608","DOIUrl":"https://doi.org/10.35248/2153-2435.19.10.608","url":null,"abstract":"","PeriodicalId":19833,"journal":{"name":"Pharmaceutica Analytica Acta","volume":"224 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73946851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Rutin: A Potential Therapeutic Agent for Alzheimer Disease 芦丁:阿尔茨海默病的潜在治疗剂
Pub Date : 2019-01-01 DOI: 10.35248/2153-2435.19.10.615
Nada M. Mostafa
Xu et al. reported that rutin decreases β-amyloid plaque aggregation, nitric oxide production, the pro-inflammatory cytokines, cytotoxicity and oxidative stress in-vitro. They additionally investigated its in-vivo neuroprotective effects on alzheimer-diseased transgenic mice, where they reported an attenuation of the memory deficits, increase of antioxidant parameters as reduced glutathione and super oxide dismutase, decrease in lipid peroxidation levels, as indicated by malondialdehyde, as well as decreased brain interleukin-1β and interleukin-6 levels [2].
Xu等人报道芦丁在体外可降低β-淀粉样斑块聚集、一氧化氮生成、促炎细胞因子、细胞毒性和氧化应激。他们还研究了其对阿尔茨海默病转基因小鼠的体内神经保护作用,在那里他们报告了记忆缺陷的减弱,抗氧化参数的增加,如减少谷胱甘肽和超氧化物歧化酶,脂质过氧化水平的降低,如丙二醛所示,以及脑白介素-1β和白介素-6水平的降低。
{"title":"Rutin: A Potential Therapeutic Agent for Alzheimer Disease","authors":"Nada M. Mostafa","doi":"10.35248/2153-2435.19.10.615","DOIUrl":"https://doi.org/10.35248/2153-2435.19.10.615","url":null,"abstract":"Xu et al. reported that rutin decreases β-amyloid plaque aggregation, nitric oxide production, the pro-inflammatory cytokines, cytotoxicity and oxidative stress in-vitro. They additionally investigated its in-vivo neuroprotective effects on alzheimer-diseased transgenic mice, where they reported an attenuation of the memory deficits, increase of antioxidant parameters as reduced glutathione and super oxide dismutase, decrease in lipid peroxidation levels, as indicated by malondialdehyde, as well as decreased brain interleukin-1β and interleukin-6 levels [2].","PeriodicalId":19833,"journal":{"name":"Pharmaceutica Analytica Acta","volume":"48 1","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90643925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
New Analytical Insights into Treatment of Chronic Diseases 慢性病治疗的新分析见解
Pub Date : 2019-01-01 DOI: 10.35248/2153-2435.19.10.617
V. Samanidou
Over the past few decades, there has been substantial progress in the chemical analysis methods and techniques of pharmaceutical entities. The role of International Pharmacopoeias and guidelines has gained more prominence with even greater recognition and attention. Particularly, the focus on the development of biopharmaceuticals has increased over the past few years. Consequently, there is greater demand for most recent and advanced knowledge of analytical pharmaceutical chemistry among pharmacy students and analytical chemists. Efforts are being made across several laboratories on development of new and advanced analytical techniques in titration; chromatography, electrophoresis and spectroscopy as the number of officially validated method gradually increase. Pharmaceutica Analytica Acta has been focusing on publishing the most recent and trending research activities addressing the emerging analytical challenges in evaluation and characterization of pharmaceutical components through different stages of drug development including drug discovery as active raw molecule, different phases of clinical development, in finished product, manufacture as well as quality control. The current issue of Pharmaceutica Chemica Acta focuses on one natural drug component and chemically synthesizes analogues of tyrosine inhibitors and presents their characteristic structural and functional properties. These components have great potential in the treatment and cure of prevailing chronic disease such as Alzheimer’s disease and Cancer.
在过去的几十年里,药物实体的化学分析方法和技术取得了长足的进步。国际药典和指南的作用得到了更大的重视和认可。特别是,在过去几年中,对生物制药发展的关注有所增加。因此,在药学学生和分析化学家中,对最新和先进的分析药物化学知识的需求更大。几个实验室正在努力开发新的和先进的滴定分析技术;随着色谱、电泳和光谱学等正式验证方法的数量逐渐增加。《Pharmaceutica Analytica Acta》一直专注于发表最新和趋势的研究活动,通过药物开发的不同阶段,包括药物发现作为活性原料分子,临床开发的不同阶段,成品,制造以及质量控制,解决药物成分评估和表征中出现的分析挑战。最近一期的《药学化学学报》重点研究了一种天然药物成分和酪氨酸抑制剂的化学合成类似物,并介绍了它们的结构和功能特性。这些成分在治疗和治愈阿尔茨海默病和癌症等慢性病方面具有巨大潜力。
{"title":"New Analytical Insights into Treatment of Chronic Diseases","authors":"V. Samanidou","doi":"10.35248/2153-2435.19.10.617","DOIUrl":"https://doi.org/10.35248/2153-2435.19.10.617","url":null,"abstract":"Over the past few decades, there has been substantial progress in the chemical analysis methods and techniques of pharmaceutical entities. The role of International Pharmacopoeias and guidelines has gained more prominence with even greater recognition and attention. Particularly, the focus on the development of biopharmaceuticals has increased over the past few years. Consequently, there is greater demand for most recent and advanced knowledge of analytical pharmaceutical chemistry among pharmacy students and analytical chemists. Efforts are being made across several laboratories on development of new and advanced analytical techniques in titration; chromatography, electrophoresis and spectroscopy as the number of officially validated method gradually increase. Pharmaceutica Analytica Acta has been focusing on publishing the most recent and trending research activities addressing the emerging analytical challenges in evaluation and characterization of pharmaceutical components through different stages of drug development including drug discovery as active raw molecule, different phases of clinical development, in finished product, manufacture as well as quality control. The current issue of Pharmaceutica Chemica Acta focuses on one natural drug component and chemically synthesizes analogues of tyrosine inhibitors and presents their characteristic structural and functional properties. These components have great potential in the treatment and cure of prevailing chronic disease such as Alzheimer’s disease and Cancer.","PeriodicalId":19833,"journal":{"name":"Pharmaceutica Analytica Acta","volume":"85 1","pages":"1-1"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83913179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Applications, Model Study and Commercial Utilization (Patents) of Ophthalmic Route as Drug Delivery Site 眼科途径作为给药位点的应用、模型研究及商业利用(专利)
Pub Date : 2019-01-01 DOI: 10.35248/2153-2435.19.10.607
Agrawal H, S. Pk, Malviya R
Ophthalmic drug delivery has been a noteworthy challenge for the researchers because of its one of a kind anatomy and physiology which consists of different sorts of boundaries, such as layers of cornea, sclera, and retina, etc. these obstructions can cause challenges for drug delivery and also in a dosage form, significantly into the posterior part of the eye. To defeat these sorts of issues different types of dosage forms have been developed such as nanoparticles, nano micelles, liposome, and micro-emulsions. Ongoing endeavors in research for ophthalmic drug delivery principally have concentrated on the frameworks which demonstrated that drugs are administered as in the form of eye drops. Because of the intense efforts of researchers, huge progressions in the following areas have been made, areas like in situ forming gels, oil in water emulsions, colloidal drug delivery systems, etc. The present article represents the overview of various factors which affects absorption and also clarifies about the use of media like bio-relevant media for eyes. This review will also explains about the transport of peptides and proteins through eyes, factors governing precipitation of drugs into eyes, vaccination through eyes as well as mechanistic study for drug absorption. Additionally, this article also summarizes different patents which are based on ophthalmic delivery of active agents. Delivery of drugs by ophthalmic route has been proved advantageous for future perspectives.
眼科药物输送对研究人员来说是一个值得注意的挑战,因为它是一种由不同种类的边界组成的解剖学和生理学,如角膜、巩膜和视网膜等层,这些障碍会给药物输送带来挑战,也会给剂量形式带来挑战,特别是进入眼睛的后部分。为了解决这些问题,人们开发了不同类型的剂型,如纳米颗粒、纳米胶束、脂质体和微乳液。正在进行的眼科给药研究主要集中在证明药物以滴眼液形式给药的框架上。由于研究人员的努力,在以下领域取得了巨大进展,如原位形成凝胶,水包油乳液,胶体药物输送系统等。本文概述了影响吸收的各种因素,并阐明了生物相关介质等介质在眼睛中的应用。本文还将介绍多肽和蛋白质通过眼睛的转运,药物进入眼睛的影响因素,通过眼睛接种疫苗以及药物吸收的机制研究。此外,本文还对基于眼科给药的各种专利进行了综述。通过眼科途径给药已被证明是有利的,为未来的前景。
{"title":"Applications, Model Study and Commercial Utilization (Patents) of Ophthalmic Route as Drug Delivery Site","authors":"Agrawal H, S. Pk, Malviya R","doi":"10.35248/2153-2435.19.10.607","DOIUrl":"https://doi.org/10.35248/2153-2435.19.10.607","url":null,"abstract":"Ophthalmic drug delivery has been a noteworthy challenge for the researchers because of its one of a kind anatomy and physiology which consists of different sorts of boundaries, such as layers of cornea, sclera, and retina, etc. these obstructions can cause challenges for drug delivery and also in a dosage form, significantly into the posterior part of the eye. To defeat these sorts of issues different types of dosage forms have been developed such as nanoparticles, nano micelles, liposome, and micro-emulsions. Ongoing endeavors in research for ophthalmic drug delivery principally have concentrated on the frameworks which demonstrated that drugs are administered as in the form of eye drops. Because of the intense efforts of researchers, huge progressions in the following areas have been made, areas like in situ forming gels, oil in water emulsions, colloidal drug delivery systems, etc. The present article represents the overview of various factors which affects absorption and also clarifies about the use of media like bio-relevant media for eyes. This review will also explains about the transport of peptides and proteins through eyes, factors governing precipitation of drugs into eyes, vaccination through eyes as well as mechanistic study for drug absorption. Additionally, this article also summarizes different patents which are based on ophthalmic delivery of active agents. Delivery of drugs by ophthalmic route has been proved advantageous for future perspectives.","PeriodicalId":19833,"journal":{"name":"Pharmaceutica Analytica Acta","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77402696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
New Dimensions of Pharmaceutical Analysis 药物分析的新维度
Pub Date : 2019-01-01 DOI: 10.35248/2153-2435.19.10.614
V. Samanidou
Over the past several decades, the analytical techniques pertaining to drug detection and characterization have evolved a great deal resulting in development, optimization and validation of vast array of methodologies and techniques. Continued efforts are being made for impurity profiling while bringing in better accuracy and precision for separation and quantification of the analytes. Pharmaceutica Analytica Acta reports these advances periodically. The current issue of the journal focuses on distribution of nasal spray droplet distribution, in silico studies on Spebrutinib and pharmaceutical analysis based on flow analysis techniques.
在过去的几十年里,与药物检测和表征有关的分析技术已经发展了很多,导致了大量方法和技术的开发、优化和验证。在为分析物的分离和定量带来更好的准确性和精密度的同时,正在继续努力进行杂质分析。《药学分析学报》定期报道这些进展。本期杂志的重点是鼻腔喷雾液滴的分布,斯佩鲁替尼的计算机研究和基于流量分析技术的药物分析。
{"title":"New Dimensions of Pharmaceutical Analysis","authors":"V. Samanidou","doi":"10.35248/2153-2435.19.10.614","DOIUrl":"https://doi.org/10.35248/2153-2435.19.10.614","url":null,"abstract":"Over the past several decades, the analytical techniques pertaining to drug detection and characterization have evolved a great deal resulting in development, optimization and validation of vast array of methodologies and techniques. Continued efforts are being made for impurity profiling while bringing in better accuracy and precision for separation and quantification of the analytes. Pharmaceutica Analytica Acta reports these advances periodically. The current issue of the journal focuses on distribution of nasal spray droplet distribution, in silico studies on Spebrutinib and pharmaceutical analysis based on flow analysis techniques.","PeriodicalId":19833,"journal":{"name":"Pharmaceutica Analytica Acta","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80355288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Cytotoxicity and Immune and Subacute Toxicity of Camptothecin-loaded Nanoparticles 喜树碱纳米颗粒细胞毒性及免疫和亚急性毒性的评价
Pub Date : 2019-01-01 DOI: 10.35248/2153-2435.19.10.604
T. Hong, Lim Sm, Y. Huang, K. Shu, Liang Lx, L. Liu, Liu Zy
CPT-loaded NPs with polyethylene glycol shells can increase its solubility in water and remain in circulation for a long time. This experiment has evaluated cytotoxicity and immune and subacute toxicity of CPT NPs. Camptothecin (CPT) was incorporated into biotin-F127-PLA or F127-PLA polymeric nanoparticles; a dialysis method was used for non-targeted CPT NPs and anti-CA125 antibodies for targeted CPT NPs. A cytotoxicity test was also conducted based on the growth inhibition of the mouse fibroblast-like L-929 cell line. The effects of the two CPT-loaded NPs on immunity were also determined through a carbon particle clearance rate assay. Each mouse was intraperitoneally injected with 0.4 ml/20 g.bw nanoparticles for 28 consecutive days in the subacute toxicity test. Results have showed that CPT NPs have reduced the toxicity of free CPT on the L-919 cells. The CPT NPs did not induce phagocytosis in the normal mice. At the end of subacute toxicity study no difference was found between the CPT NP and control groups in blood parameter analysis and main organ weight visceral coefficients. These results suggested that the new CPT NPs might elicit low toxic effects at cellular and organism levels.
具有聚乙二醇外壳的cpt负载NPs可以提高其在水中的溶解度并保持长时间的循环。本实验评价了CPT NPs的细胞毒性、免疫毒性和亚急性毒性。喜树碱(CPT)掺入生物素-F127-PLA或F127-PLA聚合物纳米颗粒中;非靶向CPT NPs采用透析法,靶向CPT NPs采用抗ca125抗体。同时对小鼠成纤维细胞样L-929细胞株进行了细胞毒性试验。两种cpt负载的NPs对免疫的影响也通过碳颗粒清除率测定来确定。每只小鼠腹腔注射0.4 ml/20 g.bw纳米颗粒,连续28天进行亚急性毒性试验。结果表明,CPT NPs降低了游离CPT对L-919细胞的毒性。CPT NPs对正常小鼠没有诱导吞噬作用。亚急性毒性研究结束时,CPT NP组与对照组在血液参数分析和主要脏器重量内脏系数方面均无差异。这些结果表明,新的CPT NPs可能在细胞和生物体水平上引起低毒性作用。
{"title":"Evaluation of the Cytotoxicity and Immune and Subacute Toxicity of Camptothecin-loaded Nanoparticles","authors":"T. Hong, Lim Sm, Y. Huang, K. Shu, Liang Lx, L. Liu, Liu Zy","doi":"10.35248/2153-2435.19.10.604","DOIUrl":"https://doi.org/10.35248/2153-2435.19.10.604","url":null,"abstract":"CPT-loaded NPs with polyethylene glycol shells can increase its solubility in water and remain in circulation for a long time. This experiment has evaluated cytotoxicity and immune and subacute toxicity of CPT NPs. Camptothecin (CPT) was incorporated into biotin-F127-PLA or F127-PLA polymeric nanoparticles; a dialysis method was used for non-targeted CPT NPs and anti-CA125 antibodies for targeted CPT NPs. A cytotoxicity test was also conducted based on the growth inhibition of the mouse fibroblast-like L-929 cell line. The effects of the two CPT-loaded NPs on immunity were also determined through a carbon particle clearance rate assay. Each mouse was intraperitoneally injected with 0.4 ml/20 g.bw nanoparticles for 28 consecutive days in the subacute toxicity test. Results have showed that CPT NPs have reduced the toxicity of free CPT on the L-919 cells. The CPT NPs did not induce phagocytosis in the normal mice. At the end of subacute toxicity study no difference was found between the CPT NP and control groups in blood parameter analysis and main organ weight visceral coefficients. These results suggested that the new CPT NPs might elicit low toxic effects at cellular and organism levels.","PeriodicalId":19833,"journal":{"name":"Pharmaceutica Analytica Acta","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87325844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Pharmaceutica Analytica Acta
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1